Daan Gene Co., Ltd. — Investor Relations & Filings
Filings indexed
2,189
across all filing types
Latest filing
2026-04-27
Regulatory Filings
Country
CN
China
Listing
Shenzhen Stock Exchange
002030
Daan Gene Co., Ltd. specializes in the development and manufacturing of molecular diagnostic products and services. The company focuses on in vitro diagnostic technologies, particularly polymerase chain reaction (PCR) platforms. Its product portfolio includes diagnostic kits for infectious diseases, genetic screening, and oncology, alongside automated nucleic acid extraction systems and real-time PCR instruments. Daan Gene provides comprehensive solutions for clinical laboratories and public health institutions, integrating research, production, and clinical testing services. The organization emphasizes technological innovation in molecular biology to support precision medicine and disease control.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 董事会对独立董事独立性评估的专项意见 | 2026-04-27 | Chinese | |
| 2025年年度报告摘要 | 2026-04-27 | Chinese | |
| 关于下属子公司取得一个医疗器械注册证的提示性公告 | 2026-03-31 | Chinese | |
| 第九届董事会2026年第二次临时会议决议公告 | 2026-03-25 | Chinese | |
| 2025年年度业绩预告 | 2026-01-30 | Chinese | |
| 第九届董事会2026年第一次临时会议决议公告 | 2026-01-30 | Chinese |
Browse filings by year
23 years- 2026 38 filings
- 2025 128 filings
- 2024 93 filings
- 2023 73 filings
- 2022 157 filings
- 2021 134 filings
- 2020 120 filings
- 2019 94 filings
- 2018 116 filings
- 2017 110 filings
- 2016 132 filings
- 2015 172 filings
- 2014 167 filings
- 2013 95 filings
- 2012 64 filings
- 2011 57 filings
- 2010 72 filings
- 2009 66 filings
- 2008 63 filings
- 2007 84 filings
- 2006 55 filings
- 2005 78 filings
- 2004 21 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 44391694 | 董事会对独立董事独立性评估的专项意见 | 2026-04-27 | Chinese | ||
| 44391688 | 2025年年度报告摘要 | 2026-04-27 | Chinese | ||
| 44391687 | 关于下属子公司取得一个医疗器械注册证的提示性公告 | 2026-03-31 | Chinese | ||
| 44391678 | 第九届董事会2026年第二次临时会议决议公告 | 2026-03-25 | Chinese | ||
| 44391672 | 2025年年度业绩预告 | 2026-01-30 | Chinese | ||
| 44391668 | 第九届董事会2026年第一次临时会议决议公告 | 2026-01-30 | Chinese | ||
| 44391657 | 股票交易异常波动公告 | 2026-01-27 | Chinese | ||
| 44391656 | 关于取得一个医疗器械注册证的提示性公告 | 2026-01-26 | Chinese | ||
|
2025
7 filings
| |||||
| 44391645 | 广州达安基因股份有限公司关于间接控股股东拟发生变更的提示性公告 | 2025-11-17 | Chinese | ||
| 44391641 | 2025年第四次临时股东会的法律意见书 | 2025-11-17 | Chinese | ||
| 44391627 | 关于选举第九届董事会职工代表董事的公告 | 2025-11-17 | Chinese | ||
| 44391625 | 2025年第四次临时股东会决议公告 | 2025-11-17 | Chinese | ||
| 44391613 | 关于取得一个医疗器械注册证的提示性公告 | 2025-10-31 | Chinese | ||
| 44391605 | 董事和高级管理人员离职管理制度 | 2025-10-30 | Chinese | ||
| 44391586 | 董事会提名委员会工作细则（2025年10月） | 2025-10-30 | Chinese | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Daan Gene Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/54093/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=54093 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=54093 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=54093 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 54093}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Daan Gene Co., Ltd. (id: 54093)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.